Since, the AR is active in CRPC and is able to transcribe AR-dependent genes either in the presence of low levels of androgens or absence of androgens [40], we determined if a decrease in LMTK2 is involved in activating AR in androgen deprived prostate cancer cells. The gene discussed is LMTK2; the disease is prostate cancer.